How has been the historical performance of Torrent Pharma?

Answer:The historical performance of Torrent Pharma shows a consistent growth trajectory in net sales and profit metrics over the years. Breakdown: Torrent Pharma's net sales have steadily increased from INR 7,673.00 crore in March 2019 to INR 11,516.00 crore in March 2025, reflecting a strong upward trend. The total operating income has followed a similar pattern, rising from INR 7,673.00 crore in March 2019 to INR 11,516.00 crore in March 2025. The company's operating profit (PBDIT) has also shown significant growth, climbing from INR 2,041.00 crore in March 2019 to INR 3,744.00 crore in March 2025, with an operating profit margin that improved from 26.59% to 32.88% over the same period. Profit before tax increased from INR 562.00 crore in March 2019 to INR 2,673.00 crore in March 2025, while profit after tax rose from INR 436.00 crore to INR 1,911.00 crore, indicating a healthy growth in profitability. The company's total assets increased from INR 13,576.53 crore in March 2020 to INR 14,395.59 crore in March 2025, while total liabilities decreased from INR 14,505.45 crore in March 2024 to INR 14,395.59 crore in March 2025, suggesting improved financial stability. Cash flow from operating activities has also been positive, although it decreased from INR 3,266.00 crore in March 2024 to INR 2,585.00 crore in March 2025. Overall, Torrent Pharma has demonstrated robust growth in sales and profitability, alongside a stable balance sheet.